Latest Research

Sonovein Receives FDA Authorization, Opening New Possibilities for Hemodynamics-Guided Venous Treatment

French medical technology company Theraclion announced on November 5 that its Sonovein® system has received De Novo marketing authorization from the U.S. Food and...

Venous Sclerosing Agents Under Renewed Safety Scrutiny: ANSM Highlights Persistent Cardiovascular Risks

Recent pharmacovigilance updates from the French National Agency for the Safety of Medicines and Health Products (ANSM) have renewed attention to the safety profile...

Pseudo-CHIVA: When Ablation Is Called CHIVA

A Conceptual Clarification and Boundary Framework in Venous Surgery Dr. Qiang Zhang Looking forward, the evolution of venous surgery should not be viewed as a conflict...

CHIVA vs. Stripping: A Decade of Evidence Supporting Hemodynamic Preservation in Varicose Vein Surgery

Introduction Varicose veins, a prevalent manifestation of chronic venous disease (CVD), are often treated surgically when symptomatic. While traditional approaches involve the removal (stripping) of...

Predictive Factors for Thrombotic Complications in Superficial Venous Thrombosis: A Review and Future Directions

Abstract:Superficial venous thrombosis (SVT) can lead to serious complications such as deep venous thrombosis (DVT) and pulmonary embolism (PE). Identifying predictive factors for these...

TOP PUBLICATIONS